Savara Inc — Director's Dealing 2014

Jan 3, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Mast Therapeutics, Inc. (MSTX)
CIK: 0001160308
Period of Report: 2014-01-02

Reporting Person: Roberts Brandi (Chief Financial Officer & SVP)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-01-02	Employee Stock Option (Right to Buy)	$0.47	A	101200	Acquired	2024-01-02	Common Stock (101200)	Direct

Footnotes

F1: This option has a January 2, 2014 vesting commencement date and vests and becomes exercisable in 48 substantially equal monthly installments over the 48-month period following the vesting commencement date, subject to the reporting person's continued service with the issuer.